跳至主要内容
临床试验/CTRI/2026/02/103576
CTRI/2026/02/103576尚未招募不适用

To Evaluate the Efficacy of Individualized Homoeopathic Medicine VS Fraxinus Americana in the Management of Uterine Fibroid A Randomized controlled Trial

Dr Pragya Varshney1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月21日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Uterine Fibroid is the commonest benign tumor of the uterus and also the commonest benign solid tumor in females. Histologically, this tumor is composed of smooth muscle and fibrous connective tissue. It has been estimated that at least 20 percent of women at the age of 30 have got fibroid in their wombs. Fortunately, most of them (50%) remain asymptomatic.  They are the leading cause of hysterectomy and a major reason for hospital admissions related to gynaecological conditions.  The conventional treatments for fibroids include GnRH analogues, myomectomy, etc., and the failure of these procedures complicate infertility further.

Homoeopathy provides an effective treatment in cases of Uterine fibroid. This study focuses on to find out  the difference  between the effectiveness of individualized homoeopathic medicine and fraxinus americana in the management of uterine fibroid  assessed by USG and severity of disease assessed by UFS-QOL questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Well diagnosed case of uterine fibroid on basis of clinical sign and symptoms along with USG
  • Female patient with age group 20-50 yrs of age
  • Patients providing written informed consent.

排除标准

  • Patients with severe anemia.hemoglobin levels greater than or equal to 7 g/dl.
  • Abnormal unexplained vaginal bleeding 3.Malignancy of genitourinary tract or history of any malignancy 4.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life- threatening infections affecting quality of life or any vital organ failure.
  • 5.Pregnancy and lactation 6.Myoma is more than 12 wks.
  • 7.Substance abuse or dependence 8.Self-reported immune-compromised state 9.Patients who are already enrolled in some other study.
  • 10.Patients unwilling for inclusion in the study and those who are not able to come for follow-up.
  • 11.Pedunculated fibroid less than 5cm in diameter 12.Very large, Calcified and multiple fibroids filling the Uterine cavity are excluded.

研究者

发起方
Dr Pragya Varshney
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pragya Varshney

State National Homoeopathic Medical College and Hospital Lucknow

研究点 (1)

Loading locations...

相似试验